Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Meir Bialer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients
Goldstein, R., Sandouka, K., Zighan, L., Ya’ari, S., Bialer, M. & Muszkat, M., 2026, (Accepted/In press) In: Clinical Pharmacokinetics.Research output: Contribution to journal › Article › peer-review
Open Access -
Enantioselective comparative analysis of the anticonvulsant potency of fenfluramine and norfenfluramine in mice
Sheeni, Y., Erenburg, N., Barasch, D., Shekh-Ahmad, T., Perucca, E. & Bialer, M., Nov 2025, In: Epilepsia. 66, 11, p. 4501-4512 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Folate transfer in placental choriocarcinoma cells treated with valproic acid: Insights gained through comparisons with the amide derivative sec-butylpropylacetamide and its individual stereoisomers
Erenburg, N., Hamed, R., Nemirovski, A., Bialer, M. & Eyal, S., Sep 2025, In: Epilepsia. 66, 9, p. 3544-3554 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
From barbiturates to ganaxolone: The importance of chirality in drug development and in understanding the actions of old and new antiseizure medications: The importance of chirality in drug development and in understanding the actions of old and new antiseizure medications
Bialer, M. & Perucca, E., Apr 2025, In: Pharmacology and Therapeutics, Part A: Chemotherapy, Toxicology and. 268, 108808.Research output: Contribution to journal › Review article › peer-review
5 Scopus citations -
Pharmacokinetics of d- and l-norfenfluramine following their administration as individual enantiomers in rats
Erenburg, N., Hamed, R., Shaul, C., Barasch, D., Perucca, E. & Bialer, M., Feb 2024, In: Epilepsia. 65, 2, p. e14-e19Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations